18 . June , 2018 - Monday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Monistat 3

Big Image
Generic Name: miconazole nitrate
Dosage Form: Vaginal suppositories

Monistat 3 Description

Monistat 3 Vaginal Suppositories are white to off-white suppositories, each containing the antifungal agent, miconazole nitrate, 1-[2,4-Dichloro-β-[(2,4-dichlorobenzyl)oxy]phenethyl]-imidazole mononitrate, 200 mg, in a hydrogenated vegetable oil base. Miconazole nitrate for vaginal use is also available as MONISTAT 7 Vaginal Cream and MONISTAT 7 Vaginal Suppositories.

Monistat 3 - Clinical Pharmacology

Miconazole nitrate exhibits fungicidal activity in vitro against species of the genus Candida. The pharmacologic mode of action is unknown. Following intravaginal administration of miconazole nitrate, small amounts are absorbed. Administration of a single dose of miconazole nitrate suppositories (100 mg) to healthy subjects resulted in a total recovery from the urine and feces of 0.85% (± 0.43%) of the administered dose.

Animal studies indicate that the drug crossed the placenta and doses above those used in humans result in embryo- and fetotoxicity (80 mg/kg, orally), although this has not been reported in human subjects (See PRECAUTIONS).

In multi-center clinical trials in 440 women with vulvovaginal candidiasis, the efficacy of treatment with the Monistat 3 Vaginal Suppository for 3 days was compared with treatment for 7 days with MONISTAT 7 Vaginal Cream. The clinical cure rates (free of microbiological evidence and clinical signs and symptoms of candidiasis at 8–10 days and 30–35 days post-therapy) were numerically lower, although statistically different, with the 3-Day Suppository when compared with the 7-Day Cream.

Indications and Usage for Monistat 3

Monistat 3 Vaginal Suppositories are indicated for the local treatment of vulvovaginal candidiasis (moniliasis). Effectiveness in pregnancy and in diabetic patients has not been established. As MONISTAT is effective only for candidal vulvovaginitis, the diagnosis should be confirmed by KOH smear and/or cultures. Other pathogens commonly associated with vulvovaginitis (Trichomonas and Haemophilus vaginalis [Gardnerella]) should be ruled out by appropriate laboratory methods.

Contraindications

Patients known to be hypersensitive to this drug.

Precautions

General

Discontinue drug if sensitization or irritation is reported during use. The base contained in the suppository formulation may interact with certain latex products, such as that used in vaginal contraceptive diaphragms. Concurrent use is not recommended. MONISTAT 7 Vaginal Cream may be considered for use under these conditions.

Laboratory Tests

If there is a lack of response to Monistat 3 Vaginal Suppositories, appropriate microbiological studies (standard KOH smear and/or cultures) should be repeated to confirm the diagnosis and rule out other pathogens.

Carcinogenesis, Mutagenesis, Impairment of Fertility

Long-term animal studies to determine carcinogenic potential have not been performed.

Fertility (Reproduction)

Oral administration of miconazole nitrate in rats has been reported to produce prolonged gestation. However, this effect was not observed in oral rabbit studies. In addition, signs of fetal and embryo toxicity were reported in rat and rabbit studies, and dystocia was reported in rat studies after oral doses at and above 80 mg per kg. Intravaginal administration did not produce these effects in rats.

Pregnancy

Since imidazoles are absorbed in small amounts from the human vagina, they should not be used in the first trimester of pregnancy unless the physician considers it essential to the welfare of the patient.

Clinical studies, during which miconazole nitrate vaginal cream and suppositories were used for up to 14 days, were reported to include 514 pregnant patients. Follow-up reports available in 471 of these patients reveal no adverse effects or complications attributable to miconazole nitrate therapy in infants born to these women.

Nursing Mothers

It is not known whether miconazole nitrate is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when miconazole nitrate is administered to a nursing woman.

Adverse Reactions

During clinical studies with Monistat 3 Vaginal Suppository (miconazole nitrate, 200 mg) 301 patients were treated. The incidence of vulvovaginal burning, itching or irritation was 2%. Complaints of cramping (2%) and headaches (1.3%) were also reported. Other complaints (hives, skin rash) occurred with less than a 0.5% incidence. The therapy-related dropout rate was 0.3%.

OVERDOSE

Overdosage of miconazole nitrate in humans has not been reported to date. In mice, rats, guinea pigs and dogs, the oral LD 50 values were found to be 578.1, > 640, 275.9 and > 160 mg/kg, respectively.

Monistat 3 Dosage and Administration

Monistat 3 Vaginal Suppositories: One suppository (miconazole nitrate, 200 mg) is inserted intravaginally once daily at bedtime for three consecutive days. Before prescribing another course of therapy, the diagnosis should be reconfirmed by smears and/or cultures to rule out other pathogens.

How is Monistat 3 Supplied

Monistat 3 Suppositories (miconazole nitrate, 200 mg) are available as 2.5 gm elliptically shaped white to off-white suppositories in packages of three (NDC 0062-5437-01) with a vaginal applicator. Store at 59–86°F (15–30°C).

ORTHO PHARMACEUTICAL CORPORATION
Raritan, New Jersey 08869

© OPC 1984
PRINTED IN USA
REV OCT. 1996
643-10-353-5


Monistat 3 (miconazole nitrate)
PRODUCT INFO
Product Code 0062-5437 Dosage Form SUPPOSITORY
Route Of Administration VAGINAL DEA Schedule
INGREDIENTS
Name (Active Moiety) Type Strength
miconazole nitrate (miconazole) Active 200 MILLIGRAM  In 1 SUPPOSITORY
hydrogenated vegetable oil Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color Score
Shape Symbol
Imprint Code Coating
Size
PACKAGING
# NDC Package Description Multilevel Packaging
1 0062-5437-01 3 SUPPOSITORY In 1 PACKAGE None

Revised: 12/2006

Recent Drug Updates at DrugIndexOnline:





Camptosar Camptosar
Generic Name: irinotecan hydrochloride Dosage Form: Injection For Intravenous Use Only Warnings Camptosar Injection should be administered only under the supervision of a physician who is experienced in the use of cancer chemotherapeutic agents. Appropriate management of complications is possi more...

Clarithromycin Suspension Clarithromycin Suspension
Generic Name: Clarithromycin Oral Suspension (kla-RITH-roe-mye-sin) Brand Name: BiaxinClarithromycin Suspension is used for:Treating infections caused by certain bacteria. Clarithromycin Suspension is a macrolide antibiotic. It works by stopping the growth of or killing sensitive bacteria by red more...

Coristex-DH Coristex-DH
Some commonly used brand names are: In the U.S.— Alka-Seltzer Plus Cold and Cough 21 Alka-Seltzer Plus Cold and Cough Medicine Liqui-Gels 34 Alka-Seltzer Plus Night-Time Cold Liqui-Gels 35 Ami-Tex LA 69 Anatuss LA 70 Benylin Expectorant 54 Bromfed-DM 17 Broncholate 68 Carbinoxamine Compou more...

Eptifibatide Eptifibatide
Generic Name: Eptifibatide (ep-ti-FIB-ih-tide) Brand Name: IntegrilinEptifibatide is used for:Treating unstable angina (chest pain) or certain types of heart attacks. It may also be used to treat patients undergoing a certain type of procedure (percutaneous coronary intervention [PCI]). It may more...

Etopophos Etopophos
Some commonly used brand names are: In the U.S.— VePesid Etopophos Toposar In Canada— VePesid Generic name product may be available in the U.S. and Canada. Another commonly used name is VP-16 . Category Antineoplastic Description Etoposide (e-toe-POE-side)belongs to the g more...

Gencold Gencold
Generic Name: chlorpheniramine and phenylpropanolamine (klor feh NEER a meen and feh nill proe pa NO la meen) Brand Names: A.R.M. Allergy Relief, Allerest 12 Hour, Chlornade, Condrin, Contac 12 Hour, Decongex-3, Demazin, Dura-Vent/A, Equi-Nade, Genamin, Gencold, Histade, Or-Phen-Ade, Ordr more...

Klor-Con M Klor-Con M
Generic Name: potassium chloride Dosage Form: Extended release tablets Klor-Con M Description Klor-Con® M20 is an immediately dispersing extended-release oral dosage form of potassium chloride containing 1500 mg of microencapsulated potassium chloride, USP equivalent to 20 mEq of potassium in more...

Nitropress Nitropress
Generic Name: sodium nitroprusside Dosage Form: Injection Fliptop Vial Rx only After reconstitution with appropriate diluent, Nitropress® (Sodium Nitroprusside Injection) is not suitable for direct injection. The reconstituted solution must be further diluted in sterile 5% dextrose inject more...